Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Ophthalmology|September 13, 2005
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edemaEmmett T Cunningham, Anthony P Adamis, Michael Altaweel, et al.
Retina (Philadelphia, Pa.)|November 25, 2010
Ischemic index and neovascularization in central retinal vein occlusionIrena Tsui, Andrew Kaines, Margaret A Havunjian, et al.
Ophthalmology|November 4, 2004
Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11Barbara S Hawkins, Neil M Bressler, Päivi H Miskala, et al.
JCI Insight|September 15, 2020
Modulating the tension-time integral of the cardiac twitch prevents dilated cardiomyopathy in murine heartsJoseph D Powers, Kristina B Kooiker, Allison B Mason, et al.
Retina (Philadelphia, Pa.)|June 22, 2012
Removal of posterior segment retained lens material using the OZil phacoemulsification handpiece versus Fragmatome during pars plana vitrectomyAllen Chiang, Sunir J Garg, Rayan A Alshareef, et al.
Lancet (London, England)|October 4, 2015
Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trialElizabeth P Rakoczy, Chooi-May Lai, Aaron L Magno, et al.
Ebiomedicine|November 21, 2016
Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular DegenerationIan J Constable, Cora M Pierce, Chooi-May Lai, et al.
Retina (Philadelphia, Pa.)|September 1, 2011
Endophthalmitis in microincision vitrectomy: outcomes of gas-filled eyesAllen Chiang, Richard S Kaiser, Robert L Avery, et al.
Lancet (London, England)|December 3, 2014
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studiesSteven D Schwartz, Carl D Regillo, Byron L Lam, et al.
Pageof 19